31.10.2022 - TORONTO, Oct. 31, 2022 (GLOBE NEWSWIRE) - Avicanna Inc. ( Avicanna or the Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid . Seite 1